In a small set of patients with GBM, tumor expression of YKL-40 was correlated with increased EC-associated vessel density and VEGF expression, and decreased patient survival [27], which agrees well with the data in pre-clinical studies. The gene discussed is VEGFA; the disease is glioblastoma.